FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medications and deals with combination of R,R-glycopyrrolate or its physiologically acceptable salts and montelukast in effective amount for treatment of respiratory diseases, selected from group, which includes allergic rhinitis, bronchial asthma, chronic obstructive lung diseases and common cold. Also described are pharmaceutical composition for treatment of respiratory diseases, which contains R,R-glycopyrrolate or its physiologically acceptable salts and montelukast in effective amount, and application of R,R-glycopyrrolate or its physiologically acceptable salts and montelukast or its physiologically acceptable salts in effective amount for preparation of pharmaceutical composition.
EFFECT: claimed combination inhibits release of IL-2 synergically.
15 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATING INFLAMMATORY AND OBSTRUCTIVE RESPIRATORY DISEASES | 2005 |
|
RU2438660C2 |
| COMBINATION (VERSIONS) AND PHARMACEUTICAL PREPARATION FOR TREATMENT OF RESPIRATORY TRACT DISEASES | 2005 |
|
RU2437658C2 |
| COMBINATION (VERSIONS) AND PHARMACEUTICAL PREPARATION FOR TREATING UPPER RESPIRATORY TRACT DISEASES | 2005 |
|
RU2440813C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND INHIBITORS PDE4 | 2005 |
|
RU2404772C2 |
| COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATMENT OF INFLAMMATORY DISEASES | 2006 |
|
RU2465915C2 |
| DRUG COMBINATION | 2014 |
|
RU2666624C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385721C2 |
| PYRIMIDOPYRIDAZINE DERIVATIVES APPLICABLE AS P38 MAP KINASE | 2010 |
|
RU2516466C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS | 2005 |
|
RU2373935C2 |
| COMBINATIONS CONTAINING ANTI-MUSCARINE PREPARATIONS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2379033C2 |
